CN101155911B - 5-氟尿嘧啶耐受菌及其制备方法 - Google Patents
5-氟尿嘧啶耐受菌及其制备方法 Download PDFInfo
- Publication number
- CN101155911B CN101155911B CN200680011344.6A CN200680011344A CN101155911B CN 101155911 B CN101155911 B CN 101155911B CN 200680011344 A CN200680011344 A CN 200680011344A CN 101155911 B CN101155911 B CN 101155911B
- Authority
- CN
- China
- Prior art keywords
- tolerance
- bacterium
- fluorouracil
- isocytosine deaminase
- bifidobacterium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (14)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005112557 | 2005-04-08 | ||
JP112557/2005 | 2005-04-08 | ||
PCT/JP2006/307102 WO2006109619A1 (ja) | 2005-04-08 | 2006-04-04 | 5-フルオロウラシル耐性菌およびその作製方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101155911A CN101155911A (zh) | 2008-04-02 |
CN101155911B true CN101155911B (zh) | 2015-08-26 |
Family
ID=37086897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200680011344.6A Expired - Fee Related CN101155911B (zh) | 2005-04-08 | 2006-04-04 | 5-氟尿嘧啶耐受菌及其制备方法 |
Country Status (10)
Country | Link |
---|---|
US (1) | US8734779B2 (zh) |
EP (1) | EP1867714B1 (zh) |
JP (1) | JP4945440B2 (zh) |
KR (1) | KR101302088B1 (zh) |
CN (1) | CN101155911B (zh) |
CA (1) | CA2603453C (zh) |
DK (1) | DK1867714T3 (zh) |
ES (1) | ES2438565T3 (zh) |
PT (1) | PT1867714E (zh) |
WO (1) | WO2006109619A1 (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101448940A (zh) | 2006-05-24 | 2009-06-03 | 阿内罗药物科学株式会社 | 基因转运载体的制备方法 |
DK2274422T3 (en) * | 2008-04-17 | 2017-07-03 | Anaeropharma Science Inc | expression |
US8338162B2 (en) * | 2009-04-17 | 2012-12-25 | Anaeropharma Science, Inc. | Obligately anaerobic mutant lactic acid bacterium and preparation method therefor, and expression vector functioning in obligately anaerobic lactic acid bacterium |
KR20170002403A (ko) | 2014-05-01 | 2017-01-06 | 가부시키가이샤 아네로파마·사이엔스 | 이종 폴리펩티드 발현 카세트 |
CZ309218B6 (cs) * | 2014-08-26 | 2022-06-01 | Univerzita Palackého v Olomouci | Způsob stanovení aktivity enzymů přeměňujících cytosinové deriváty na uracilové deriváty v buňkách a tkáních |
US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
US11471497B1 (en) | 2019-03-13 | 2022-10-18 | David Gordon Bermudes | Copper chelation therapeutics |
US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6110737A (en) | 1988-02-02 | 2000-08-29 | The Regents Of The University Of California | Human platelet-derived growth factor receptor, type A |
US6190657B1 (en) | 1995-06-07 | 2001-02-20 | Yale University | Vectors for the diagnosis and treatment of solid tumors including melanoma |
CA2302866C (en) | 1997-09-10 | 2012-02-21 | Vion Pharmaceuticals, Inc. | Genetically modified tumor-targeted bacteria with reduced virulence |
US6080849A (en) | 1997-09-10 | 2000-06-27 | Vion Pharmaceuticals, Inc. | Genetically modified tumor-targeted bacteria with reduced virulence |
AU7572900A (en) | 1999-08-26 | 2001-03-19 | Vion Pharmaceuticals, Inc. | Compositions and methods for delivery of an agent using attenuated salmonella containing phage |
US6962696B1 (en) | 1999-10-04 | 2005-11-08 | Vion Pharmaceuticals Inc. | Compositions and methods for tumor-targeted delivery of effector molecules |
JP3642755B2 (ja) | 2000-09-21 | 2005-04-27 | 純 天野 | 嫌気性菌を用いた遺伝子治療用医薬 |
CA2342040C (en) | 2000-09-21 | 2012-07-10 | Kyowa Hakko Kogyo Co., Ltd. | Anaerobic bacterium as a drug for cancer gene therapy |
KR100457879B1 (ko) | 2001-02-24 | 2004-11-18 | 주식회사 비피도 | 비피도박테리움 유래 신규 플라스미드, 이를 이용한 재조합 발현 벡터 및 형질전환 방법 |
JP4356501B2 (ja) | 2003-04-25 | 2009-11-04 | チッソ株式会社 | 難燃性繊維及びそれを用いた繊維成形体 |
-
2006
- 2006-04-04 JP JP2007512917A patent/JP4945440B2/ja not_active Expired - Fee Related
- 2006-04-04 ES ES06731050.8T patent/ES2438565T3/es active Active
- 2006-04-04 KR KR1020077025746A patent/KR101302088B1/ko active IP Right Grant
- 2006-04-04 WO PCT/JP2006/307102 patent/WO2006109619A1/ja active Application Filing
- 2006-04-04 CN CN200680011344.6A patent/CN101155911B/zh not_active Expired - Fee Related
- 2006-04-04 US US11/910,880 patent/US8734779B2/en active Active
- 2006-04-04 PT PT67310508T patent/PT1867714E/pt unknown
- 2006-04-04 CA CA2603453A patent/CA2603453C/en not_active Expired - Fee Related
- 2006-04-04 EP EP06731050.8A patent/EP1867714B1/en not_active Not-in-force
- 2006-04-04 DK DK06731050.8T patent/DK1867714T3/da active
Also Published As
Publication number | Publication date |
---|---|
KR20080006583A (ko) | 2008-01-16 |
CA2603453C (en) | 2015-01-27 |
EP1867714A4 (en) | 2008-12-31 |
EP1867714B1 (en) | 2013-09-18 |
EP1867714A1 (en) | 2007-12-19 |
DK1867714T3 (da) | 2013-12-09 |
KR101302088B1 (ko) | 2013-08-30 |
PT1867714E (pt) | 2013-12-05 |
US8734779B2 (en) | 2014-05-27 |
JPWO2006109619A1 (ja) | 2008-11-06 |
WO2006109619A1 (ja) | 2006-10-19 |
ES2438565T3 (es) | 2014-01-17 |
CA2603453A1 (en) | 2006-10-19 |
US20090280091A1 (en) | 2009-11-12 |
CN101155911A (zh) | 2008-04-02 |
JP4945440B2 (ja) | 2012-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101155911B (zh) | 5-氟尿嘧啶耐受菌及其制备方法 | |
CN102834514B (zh) | 转化用质粒 | |
CN110049760A (zh) | 用于治疗炎性疾病的组合物及其用途以及益生菌组合物 | |
CN102046190B (zh) | 用于缺氧疾病的治疗剂 | |
CN102747074B (zh) | 基因转运载体的制备方法 | |
ES2357372T3 (es) | Nuevo vector lanzadera. | |
CN103917639B (zh) | 经修饰的革兰氏阳性细菌及其用途 | |
US8741622B2 (en) | Stress tolerant Bifidobacteria | |
CN107002090A (zh) | 异源多肽表达盒 | |
King et al. | Tumor-targeted Salmonella typhimurium overexpressing cytosine deaminase: a novel, tumor-selective therapy | |
Peterson et al. | Linked transformation of bacterial and prophage markers in Bacillus subtilis 168 lysogenic for bacteriophage φ105 | |
CN104321065A (zh) | 减少息肉病和结肠直肠癌的方法 | |
KR20020069324A (ko) | 비피도박테리움 유래 신규 플라스미드, 이를 이용한재조합 발현 벡터 및 형질전환 방법 | |
WO2021123391A1 (en) | Genetically modified clostridium strains and uses thereof | |
EP2057266B1 (en) | Genetic remodeling in bifidobacterium | |
CN114456992B (zh) | “自体裂解”沙门氏菌菌株、其制备方法及其在肿瘤治疗中的应用 | |
WO2022006748A1 (en) | Genetically engineered live bacteria and methods of constructing the same | |
CN116478895A (zh) | 重组鼠伤寒沙门氏菌基因工程菌hcs1、菌剂及其应用 | |
KR20040072545A (ko) | 비피도박테리움 롱검 mg1 유래 신규 플라스미드를함유하는 셔틀벡터 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: Tokyo, Japan, Japan Millennium Dai Tian District, Shen Tian Shen Bao 1-103 Tokyo garden tower 201 Patentee after: Anaeropharma Science, Inc. Address before: Tokyo, Japan Patentee before: Anaeropharma Science, Inc. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210608 Address after: Washington, USA Patentee after: Asusa Medical Sciences Ltd. Address before: Tokyo, Japan, Japan Millennium Dai Tian District, Shen Tian Shen Bao 1-103 Tokyo garden tower 201 Patentee before: Anaeropharma Science, Inc. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150826 |